Plexus (NASDAQ:PLXS) Releases Q2 2025 Earnings Guidance

Plexus (NASDAQ:PLXS) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.460-1.610 for the period, compared to the consensus earnings per share estimate of 1.610. The company issued revenue guidance of $960.0 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion.

Plexus Price Performance

PLXS traded up $0.17 during trading on Wednesday, reaching $170.49. 273,131 shares of the company traded hands, compared to its average volume of 152,915. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.71 and a current ratio of 1.51. The firm has a fifty day simple moving average of $162.01 and a 200 day simple moving average of $141.04. Plexus has a 12-month low of $90.18 and a 12-month high of $172.89. The company has a market cap of $4.62 billion, a P/E ratio of 42.52 and a beta of 0.91.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.30. The firm had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.44 EPS. On average, equities analysts forecast that Plexus will post 6.13 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on PLXS. Stifel Nicolaus upped their price objective on shares of Plexus from $136.00 to $150.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Needham & Company LLC lifted their price target on Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. Benchmark increased their price objective on Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a report on Monday, October 28th. StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Finally, KeyCorp began coverage on shares of Plexus in a report on Tuesday, October 22nd. They issued a “sector weight” rating on the stock. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $159.00.

Insiders Place Their Bets

In related news, CFO Patrick John Jermain sold 5,045 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $143.13, for a total transaction of $722,090.85. Following the transaction, the chief financial officer now owns 24,602 shares of the company’s stock, valued at approximately $3,521,284.26. This represents a 17.02 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the transaction, the chief executive officer now directly owns 74,271 shares of the company’s stock, valued at approximately $11,615,241.69. This represents a 1.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,091 shares of company stock valued at $5,377,960 over the last quarter. 1.76% of the stock is owned by insiders.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.